HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Smriti Iyengar Selected Research

LY686017

2/2010Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Smriti Iyengar Research Topics

Disease

34Pain (Aches)
01/2021 - 09/2001
13Neuralgia (Stump Neuralgia)
01/2017 - 09/2002
9Chronic Pain
01/2021 - 06/2010
7Hyperalgesia
05/2014 - 09/2001
6Fibromyalgia (Fibrositis)
11/2011 - 09/2004
4Low Back Pain (Lumbago)
01/2021 - 06/2010
3Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 12/2009
3Osteoarthritis
06/2014 - 06/2010
3Nausea
06/2014 - 02/2006
3Dizziness (Lightheadedness)
06/2014 - 02/2006
3Major Depressive Disorder (Major Depressive Disorders)
12/2005 - 01/2004
2Postherpetic Neuralgia
01/2021 - 07/2015
2Virus Diseases (Viral Diseases)
01/2021 - 07/2015
2Postoperative Pain
01/2021 - 07/2015
2Migraine Disorders (Migraine)
01/2019 - 01/2017
2Acute Pain
02/2016 - 09/2001
2Fatigue
01/2016 - 06/2010
1Neurogenic Inflammation
01/2017
1Arthralgia (Joint Pain)
01/2016
1Ejaculatory Dysfunction
01/2016
1Cough
01/2016
1Erythema
01/2016
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2016
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2016
1Vomiting
06/2014
1Central Nervous System Diseases (CNS Diseases)
06/2013
1Constipation
06/2010
1Diarrhea
06/2010
1Hyperhidrosis
06/2010
1Social Phobia
02/2010
1Knee Osteoarthritis
12/2009
1Asthenia
09/2007
1Diabetes Complications
09/2006
1Edema (Dropsy)
02/2006
1Sleepiness
02/2006
1Type 2 Diabetes Mellitus (MODY)
07/2005
1Diabetic Neuropathies (Diabetic Neuropathy)
07/2005
1Polyneuropathies (Polyneuropathy)
07/2005
1Neurologic Manifestations (Neurological Manifestations)
11/2004
1Nociceptive Pain
11/2004
1Medically Unexplained Symptoms
01/2004

Drug/Important Bio-Agent (IBA)

14Duloxetine Hydrochloride (Cymbalta)FDA Link
11/2011 - 01/2004
9Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2010 - 01/2004
9Serotonin (5 Hydroxytryptamine)IBA
06/2010 - 01/2004
8Analgesics (Analgesic Drugs)IBA
11/2020 - 12/2009
7Formaldehyde (Formol)FDA Link
06/2013 - 09/2001
3Pharmaceutical PreparationsIBA
01/2020 - 12/2011
3Buprenorphine (Subutex)FDA LinkGeneric
04/2013 - 12/2011
3CarrageenanIBA
10/2006 - 09/2001
3Capsaicin (Zostrix)FDA Link
10/2006 - 09/2001
2ElementsIBA
01/2021 - 07/2015
2Opioid Analgesics (Opioids)IBA
01/2020 - 01/2020
2Calcitonin Gene-Related PeptideIBA
01/2019 - 01/2017
2Ionotropic Glutamate ReceptorsIBA
06/2014 - 05/2014
2dasolampanel etibutilIBA
06/2014 - 05/2014
2ProdrugsIBA
12/2013 - 06/2005
2Serotonin and Noradrenaline Reuptake InhibitorsIBA
06/2013 - 12/2009
1Anesthetics (Anesthetic Agents)IBA
11/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1SolutionsIBA
01/2016
1Testosterone (Sustanon)FDA Link
01/2016
1Prostate-Specific Antigen (Semenogelase)IBA
01/2016
1Gabapentin (Neurontin)FDA LinkGeneric
05/2014
1PyrrolidinesIBA
06/2013
1N-dodecyl-L-lysine amideIBA
03/2013
1Substance PIBA
09/2012
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
09/2012
1Aprepitant (Emend)FDA Link
12/2011
1Neurokinin-1 Receptor AntagonistsIBA
02/2010
1LY686017IBA
02/2010
1Amino AcidsFDA Link
10/2006
1Kainic Acid Receptors (Kainate Receptor)IBA
10/2006
1Prescription DrugsIBA
09/2006
1EstersIBA
06/2005
1Gluk1 kainate receptorIBA
06/2005
1thionisoxetineIBA
11/2004
1Milnacipran (Ixel)FDA Link
11/2004
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
11/2004
1Paroxetine (Paxil)FDA LinkGeneric
11/2004
1Glutamic Acid (Glutamate)FDA Link
09/2002
1LY 389795IBA
09/2002
1LY 379268IBA
09/2002
1eglumetadIBA
09/2002
1Scopolamine (Hyoscine)FDA Link
09/2001
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
09/2001
1Muscarinic AgonistsIBA
09/2001
1LY 297802 (vedaclidine)IBA
09/2001

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2021 - 01/2009
3Therapeutics
01/2020 - 02/2006
3Ligation
11/2004 - 09/2002
2Secondary Prevention
01/2021 - 07/2015
2Oral Administration
12/2013 - 04/2012
1Analgesia
04/2013